Tandem Diabetes Care, Inc.
TNDM
$14.41
$0.070.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 84.38% | -178.01% | 8.97% | -70.05% | -205.64% |
| Total Depreciation and Amortization | 4.48% | 5.89% | 6.70% | 6.30% | 6.63% |
| Total Amortization of Deferred Charges | 14.06% | -11.16% | -11.55% | 6.90% | -22.31% |
| Total Other Non-Cash Items | -79.97% | 1.54% | -9.42% | -1.97% | 350.88% |
| Change in Net Operating Assets | 163.24% | -0.93% | -118.88% | 207.94% | -218.56% |
| Cash from Operations | 160.48% | -8.66% | -69.14% | -80.02% | -128.59% |
| Capital Expenditure | -111.40% | -117.82% | 21.89% | 4.02% | 33.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,656.91% | -202.62% | 268.03% | 2,098.77% | 2,128.55% |
| Cash from Investing | -2,227.67% | -398.92% | 203.22% | 1,742.09% | 281.69% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 13.12% | -- | -- | -- |
| Repurchase of Common Stock | 63.82% | -- | 65.26% | -- | 85.12% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,948.14% | 13.12% | 65.26% | -1,222.88% | -134.51% |
| Foreign Exchange rate Adjustments | 42.77% | -41.37% | 159.20% | 202.24% | -344.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 666.35% | -106.50% | 1,974.14% | 193.41% | -14,208.11% |